Your email has been successfully added to our mailing list.

×
0.00817438692098085 0.00817438692098085 0.00817438692098085 0.0408719346049046 -0.00272479564032701 0.0108991825613079 0.0163487738419619 0.00272479564032701
Stock impact report

Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress

CELLULAR BIOMEDICINE GROUP INC (CBMG) 
Last cellular biomedicine group inc earnings: 11/6 04:25 pm Check Earnings Report
US:NASDAQ Investor Relations: cellbiomedgroup.com/investor-relations
Company Research Source: GlobeNewswire
China Food and Drug Administration Accepts the Company’s Investigational New Drug (IND) Applications for anti-CD19 CAR-T Therapy Targeting NHL and ALLPositive 48-Week Phase I Clinical Data of AlloJoinTM haMPC therapy for KOA in ChinaEnded quarter with $45.6 million in Cash SHANGHAI, China and CUPERTINO, Calif., May 08, 2018 (GLOBE NEWSWIRE) --  Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today reported financial results and business highlights for the first quarter ended March 31, 2018. “Early in 2018, we’ve made notable progress with our immuno-oncology platform as the China Food and Drug Administration (CFDA) accepted the Company’s Investigational New Drug Applications (IND) for “C-CAR011” anti-CD19 chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of adult patients with B-cell Non-Hodg Show less Read more
Impact Snapshot
Event Time:
CBMG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CBMG alerts
Opt-in for
CBMG alerts

from News Quantified
Opt-in for
CBMG alerts

from News Quantified